Research Papers:

A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy (IMRT)

Min Kang, Pingting Zhou, Jianxiong Long, Guisheng Li, Haolin Yan, Guosheng Feng, Meilian Liu, Jinxian Zhu and Rensheng Wang _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:94188-94196. https://doi.org/10.18632/oncotarget.21615

Metrics: PDF 1838 views  |   HTML 1933 views  |   ?  


Min Kang1, Pingting Zhou1, Jianxiong Long2, Guisheng Li3, Haolin Yan4, Guosheng Feng5, Meilian Liu6, Jinxian Zhu7 and Rensheng Wang1

1Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Radiation Oncology Clinical Medical Research Center of Guangxi, Nanning 530021, Guangxi, China

2School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China

3Department of Radiation Oncology, Liuzhou Worker Hospital, Liuzhou 545000, Guangxi, China

4Department of Radiation Oncology, First People’s Hospital of Yulin City, Yulin 537000, Guangxi, China

5Department of Radiation Oncology, People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, Guangxi, China

6Department of Radiation Oncology, Affiliated Hospital of Guilin Medical University, Guilin 541000, Guangxi, China

7Department of Radiation Oncology, Wuzhou Red Cross Hospital, Wuzhou 543000, Guangxi, China

Correspondence to:

Rensheng Wang, email: [email protected]

Keywords: nasopharyngeal carcinoma (NPC), staging system, UICC/AJCC, magnetic resonance imaging (MRI), intensity-modulated radiation therapy (IMRT)

Received: June 20, 2017    Accepted: August 04, 2017    Published: October 07, 2017


Objective: This study is to establish a new staging system for nasopharyngeal carcinoma (NPC) based on the magnetic resonance imaging (MRI) and intensity-modulated radiation therapy (IMRT).

Methods: Totally 492 patients with nasopharyngeal carcinoma were included in this study. These patients were diagnosed by pathological detection (without distant metastasis) and underwent the initial treatment of IMRT. These patients were subjected to the staging with the International Union against Cancer/American Joint Committee on Cancer (UICC/AJCC) staging system. Survival rates were calculated by the Kaplan-Meier method. Log-rank test was used to calculate the single factor prognosis, and the COX risk model was used to analyze the multivariate prognosis.

Results: In these 492 patients, according to our recommended new T and N staging criteria, there were 290 cases of T1 and 202 cases of T2; there were 64 cases of N0, 159 cases of N1, 226 cases of N2, and 43 cases of N3. Univariate and multivariate analyses showed that the T and N staging combination parameters were independent prognostic factors, which affected the overall survival rates and tumor-free survival rates. According to risk difference and survival curve distribution, the following new clinical staging criteria were established: stage I (T1N0M0), stage II (T1N1M0 and T2N0M0), stage III (T1N2M0 and T2N1-2M0), stage IVa (T1-2N3M0), and stage IVb (TxNxM1).

Conclusion: A new staging system for NPC based on MRI and IMRT has been recommended, which provides valuable evidence for disease treatment and prognosis prediction.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21615